AnalystsMark BreidenbachMark Breidenbach's Stock Forecasts
AnalystsMark Breidenbach
Sectors:
Industries:
Analyst Ranking
Top 15%
#693 out of 4873 analysts
Average Return
+14.9%
Win Rate
35%23 out of 66
Risk vs Reward
Poor
Good
Mark Breidenbach's 5 best and worst ratings
| Name / Ticker | Gain/Loss | Entry Price | Exit Price | Period | Rating |
|---|---|---|---|---|---|
Alpine Immune Sciences IncALPN | +493.88% | $10.94 | $64.97 | 2023-06-25 - 2024-05-17 | Buy |
Seres Therapeutics IncMCRB | +476.75% | $71.40 | $411.80 | 2020-03-30 - 2021-03-31 | Buy |
Alpine Immune Sciences IncALPN | +428.05% | $7.45 | $39.34 | 2023-03-23 - 2024-03-22 | Buy |
Alpine Immune Sciences IncALPN | +405.60% | $12.85 | $64.97 | 2023-09-10 - 2024-05-17 | Buy |
Compugen LtdCGEN | +225.32% | $0.79 | $2.57 | 2023-02-27 - 2024-02-28 | Buy |
Mark Breidenbach Analyst Color
Get additional color on Mark Breidenbach's coverage of popular stocks
Mark Breidenbach's Stock Coverage
| Name / Ticker | No. Ratings | Rating | Price Target | Upside/Downside | Action | Date |
|---|---|---|---|---|---|---|
Nurix Therapeutics IncNRIX | 4 | Buy | $30.00 | +211.20% | Maintains | 8 months ago |
Allogene Therapeutics IncALLO | 5 | Buy | $13.00 | +1,001.69% | Maintains | a year ago |
Essa Pharma IncEPIX | 4 | Buy | $17.00 | N/A | Reiterates | a year ago |
Alpine Immune Sciences IncALPN | 4 | Buy | $22.00 | N/A | Maintains | 2 years ago |
Arvinas IncARVN | 5 | Buy | $95.00 | N/A | Reiterates | 2 years ago |
Immuneering CorpIMRX | 3 | Buy | $25.00 | N/A | Reiterates | 2 years ago |
Cue Biopharma IncCUE | 5 | Buy | $10.00 | N/A | Assumes | 2 years ago |
Seres Therapeutics IncMCRB | 4 | Buy | $240.00 | N/A | Assumes | 2 years ago |
Biolinerx LtdBLRX | 1 | Buy | $160.00 | N/A | Reiterates | 2 years ago |
Gamida Cell LtdGMDAQ | 4 | Buy | $6.00 | N/A | Maintains | 2 years ago |
Compugen LtdCGEN | 6 | Buy | $7.00 | N/A | Maintains | 2 years ago |
Caribou Biosciences IncCRBU | 2 | Buy | $32.00 | N/A | Maintains | 2 years ago |
Syros Pharmaceuticals IncSYRS | 3 | Buy | $13.00 | N/A | Maintains | 2 years ago |
Iovance Biotherapeutics IncIOVA | 5 | Buy | $15.00 | N/A | Maintains | 2 years ago |
Synlogic IncSYBX | 2 | Buy | $120.00 | N/A | Maintains | 3 years ago |
Forma Therapeutics Holdings IncFMTX | 1 | Hold | N/A | N/A | Downgrades | 3 years ago |
Global Blood Therapeutics IncGBT | 2 | Buy | $86.00 | N/A | Maintains | 3 years ago |
Kadmon Holdings IncKDMN | 1 | Buy | $9.00 | N/A | Maintains | 4 years ago |
Achilles Therapeutics PLCACHL | 1 | Buy | $23.00 | N/A | Initiates Coverage On | 4 years ago |
Mustang Bio IncMBIO | 2 | Buy | $9,750.00 | N/A | Maintains | 5 years ago |
Bluebird Bio IncBLUE | 3 | Buy | $2,700.00 | N/A | Upgrades | 5 years ago |
Sorrento Therapeutics IncSRNEQ | 1 | Buy | $6.00 | N/A | Maintains | 7 years ago |
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.